Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Tokio Marine Asset Management Co. Ltd.

Tokio Marine Asset Management Co. Ltd. raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.5% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 10,476 shares of the medical equipment provider’s stock after purchasing an additional 455 shares during the period. Tokio Marine Asset Management Co. Ltd.’s holdings in Intuitive Surgical were worth $5,468,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the stock. Berbice Capital Management LLC acquired a new position in Intuitive Surgical in the fourth quarter valued at $26,000. Godsey & Gibb Inc. raised its holdings in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. acquired a new position in shares of Intuitive Surgical in the 3rd quarter valued at about $33,000. Decker Retirement Planning Inc. purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth about $36,000. Finally, Capital Performance Advisors LLP acquired a new stake in Intuitive Surgical during the 3rd quarter worth approximately $38,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on ISRG shares. Bernstein Bank boosted their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research note on Monday, January 27th. Royal Bank of Canada upped their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. JPMorgan Chase & Co. raised their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. CICC Research began coverage on Intuitive Surgical in a research report on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price for the company. Finally, Stifel Nicolaus raised their target price on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, December 5th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Insider Transactions at Intuitive Surgical

In other news, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Jamie Samath sold 22,903 shares of the stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the sale, the insider now owns 8,757 shares in the company, valued at approximately $4,597,425. This trade represents a 72.34 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 28,843 shares of company stock worth $15,357,560. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $571.88 on Friday. The stock has a 50-day simple moving average of $550.40 and a 200 day simple moving average of $508.94. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The company has a market capitalization of $203.69 billion, a price-to-earnings ratio of 89.22, a price-to-earnings-growth ratio of 5.52 and a beta of 1.39.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.